期刊论文详细信息
Diagnostic Pathology
Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects
Xiaoye Zhang1  Li Yu1  Zhaoguo Xu1 
[1] Department of Oncology, Shengjing Hospital Affiliated to China Medical University, Shenyang 110003, China
关键词: Meta-analysis;    Lung cancer;    Susceptibility;    Polymorphism;    hOGG1;   
Others  :  805335
DOI  :  10.1186/1746-1596-8-144
 received in 2013-07-11, accepted in 2013-08-08,  发布年份 2013
PDF
【 摘 要 】

Objectives

The Ser326Cys polymorphism in the human 8-oxogunaine glycosylase (hOGG1) gene with lung cancer susceptibility had been investigated, but results were inconsistent and underpowered. The aim of this study was to conduct a meta-analysis assessing the association of hOGG1 Ser326Cys polymorphism with risk of lung cancer.

Materials and methods

Relevant studies were identified through a search of MEDLINE, PubMed, Web of Science, EMBASE, and Chinese Biomedical Literature database (CBM) using terms “lung cancer”, “hOGG1” or “OGG1”, “polymorphism” or “variation” and the last search updated on May 1, 2013. In this meta-analysis, we assessed 30 published studies involving 22,475 subjects that investigated the association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.

Results

Overall, the hOGG1 Ser326Cys polymorphism was not associated with lung cancer susceptibility in different genetic models (dominant model comparison: OR = 0.133; 95% CI = 0.111–0.161; Pheterogeneity = 0.000), and recessive model: OR = 0.543; 95% CI = 0.399–0.739; Pheterogeneity = 0.000). Similarly, in the stratified analyses by ethnicity, significantly increased risks were found among Asians for homozygote comparison (OR = 0.850; 95% CI = 0.732 0.986; Pheterogeneity = 0.064), and dominant model (OR = 0.160; 95% CI = 0.137–0.187; Pheterogeneity = 0.001), and Caucasians for dominant model (OR = 1.35; 95% CI = 1.03–1.77; Pheterogeneity = 0.015), and recessive model (OR = 1.35; 95% CI = 1.03–1.77; Pheterogeneity = 0.015). In population-based populations, marginally significant increased risks were found in dominant model (OR = 0.143; 95% CI = 0.111 0.184; Pheterogeneity = 0.000) and recessive model (OR = 0.429; 95% CI = 0.261–0.705; Pheterogeneity = 0.000). We also found a significant difference between hOGG1 Ser326Cys genotype and lung cancer susceptibility in studies with hospital-based controls for homozygote model (OR = 0.798; 95% CI = 0.649–0.982; Pheterogeneity = 0.007),dominant model (OR = 0.122; 95% CI = 0.091–0.163; Pheterogeneity = 0.000).

Conclusion

Our data showed that the hOGG1 Ser326Cys polymorphism contributed to the risk of lung cancer.

Virtual slides

The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/3842531131031605 webcite

【 授权许可】

   
2013 Xu et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140708074832892.pdf 933KB PDF download
Figure 4. 33KB Image download
Figure 3. 91KB Image download
Figure 2. 90KB Image download
Figure 1. 84KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Li Z, Guan W, Li MX, Zhong ZY, Qian CY, Yang XQ, Liao L, Li ZP, Wang D: Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population. Arch Med Res 2011, 42(3):226-234.
  • [2]Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29.
  • [3]Dubey S, Powell CA: Update in lung cancer 2008. Am J Respir Crit Care Med 2009, 179(10):860-868.
  • [4]National Cancer Institute: SEER stat fact sheets: lung and bronchus. http://seer.cancer.gov/statfacts/html/lungb.html webcite. Accessed October 1, 2012
  • [5]Cancer Research UK: Lung cancer incidence statistics. http://info.cancerresearchuk.org/cancerstats/types/lung/incidence/ webcite. Accessed October 1, 2012
  • [6]Fearon ER: Human cancer syndromes: clues to the origin and nature of cancer. Science 1997, 278(5340):1043-1050.
  • [7]Marnett LJ: Oxyradicals and DNA damage. Carcinogenesis 2000, 21(3):361-370.
  • [8]Shi Y, Wu H, Zhang M, Ding L, Meng F, Fan X: Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagnostic Pathology 2013, 8:89. BioMed Central Full Text
  • [9]Guzmán L, Depix M, Salinas A, Roldán R, Aguayo F, Silva A, Vinet R: Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers. Diagnostic Pathology 2012, 7:87. BioMed Central Full Text
  • [10]Ji M, Zhang Y, Shi B, Hou P: Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC). Diagnostic Pathology 2011, 6:48. BioMed Central Full Text
  • [11]Muyal J, Muyal V, Kaistha B, Seifart C, Fehrenbach H: Systematic comparison of RNA extraction techniques from frozen and fresh lung tissues: checkpoint towards gene expression studies. Diagnostic Pathology 2009, 4:9. BioMed Central Full Text
  • [12]Floyd RA: The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990, 11(9):1447-1450.
  • [13]Helbock HJ, Beckman KB, Ames BN: 8-Hydroxydeoxygua-nosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. Methods Enzymol 1999, 300:156-166.
  • [14]Shinmura K, Yokota J: The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 2001, 3(4):597-607.
  • [15]Sakumi K, Tominaga Y, Furuichi M, et al.: OGG1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res 2003, 63(5):902-905.
  • [16]Kohno T, Shinmura K, Tosaka M, et al.: Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16(25):3219-3225.
  • [17]Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA: 8- Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 1992, 267:166-172.
  • [18]Hazra TK, Hill JW, Izumi T, Mitra S: Multiple DNA glycosylases for repair of 8-oxoguanine and their potential in vivo functions. Prog Nucleic Acid Res Mol Biol 2001, 68:193-205.
  • [19]Boiteux S, Radicella JP: The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 2000, 377:1.
  • [20]Park J, Chen L, Tockman MS, et al.: The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 2004, 14(2):103-109.
  • [21]Lan Q, Mumford JL, Shen M, et al.: Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 2004, 25(11):2177-2181.
  • [22]Le Marchand L, Donlon T, Lum-Jones A, et al.: Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11(4):409-412.
  • [23]Vogel U, Nexo BA, Wallin H, Overvad K, Tjonneland A, Raaschou-Nielsen O: No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem Genet 2004, 42:453-460.
  • [24]Loft S, Svoboda P, Kasai H, Tjønneland A, Vogel U, Møller P, Overvad K, Raaschou-Nielsen O: Prospective study of 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis 2006, 27(6):1245-1250.
  • [25]Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, et al.: DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006, 27(5):997-1007.
  • [26]Sorensen M, Raaschou-Nielsen O, Hansen RD, Tjonneland A, Overvad K, Vogel U: Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. Free Radic Res 2006, 40:885-891.
  • [27]Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, et al.: Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27(3):560-567.
  • [28]Hatt L, Loft S, Risom L, Møller P, Sørensen M, et al.: OGG1 expression and OGG1 Ser326Cys polymorphism and risk of lung cancer in a prospective study. Mutat Res 2008, 639(1–2):45-54.
  • [29]Karahalil B, Emerce E, Koçer B, Han S, Alkiş N, Karakaya AE: The association of OGG1 Ser326Cys polymorphism and urinary 8-OHdG levels with lung cancer susceptibility: a hospital-based case–control study in Turkey. Arh Hig Rada Toksikol 2008, 59(4):241-250.
  • [30]Okasaka T, Matsuo K, Suzuki T, Ito H, Hosono S, et al.: hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. J Hum Genet 2009, 54(12):739-745.
  • [31]Qian Q, Liu R, Lei Z, You J, Zhou Q, Zhang HT: Meta analysis of association between Ser326Cys polymorphism of hOGG1 gene and risk of lung cancer. Zhongguo Fei Ai Za Zhi 2011, 14(3):205-210.
  • [32]Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, et al.: OGG1 Ser326Cys polymorphism and lung cancer susceptibility. CEBP 1999, 8:669-674.
  • [33]Wikman H, Risch A, Klimek F, Schmezer P, Spiegelhalder B, et al.: OGG1 polymorphısm and loss of heterozygosıty (LOH): Significance for lung cancer susceptibility in a caucasian population. Int J Cancer 2000, 88:932-937.
  • [34]Ito H, Hamajima N, Takezaki T, Matsuo K, Tajima K, et al.: Limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol 2002, 12:258-265.
  • [35]Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, et al.: Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 2002, 11(8):730-738.
  • [36]Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, et al.: Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005, 97:567-576.
  • [37]Liang G, Pu Y, Yin L: Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer Lett 2005, 223(2):265-274.
  • [38]Wang W: Genetic polymorphism in Hoggle and susceptibility to lung cancer. Carcinogenesis, Teratogenesis & Mutagenesis 2005, 17:101-103.
  • [39]Kohno T, Kunitoh H, Toyama K, Yamamoto S, Kuchiba A, et al.: Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci 2006, 97(8):724-728.
  • [40]De Ruyck K, Szaumkessel M, De Rudder I, et al.: Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutation Research 2007, 631(2):101-110.
  • [41]Chang CH, Hsiao CF, Chang GC, Tsai YH, Chen YM, et al.: Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case–control study in Taiwan. Am J Epidemiol 2009, 170(6):695-702.
  • [42]Gao F: The study of the relationship between the polymorphism of hOGG1 genes and XPD genes and susceptibility to lung cancer. China: Master degree thesis, Kunming Medical College; In Chinese
  • [43]Miyaishi A, Osawa K, Osawa Y, Inoue N, Yoshida K, et al.: MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J Exp Clin Cancer Res 2009, 28:10. BioMed Central Full Text
  • [44]Liu CJ, Hsia TC, Tsai RY, Sun SS, Wang CH, et al.: The joint effect of hOGG1 single nucleotide polymorphism and smoking habit on lung cancer in Taiwan. Anticancer Res 2010, 30(10):4141-4145.
  • [45]Janik J, Swoboda M, Janowska B, Cieśla JM, Gackowski D, et al.: 8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes. Mutat Res 2011, 709–710:21-31.
  • [46]Kohno T, Kunitoh H, Mimaki S, Shiraishi K, Kuchiba A, Yamamoto S, Yokota J: Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma. J Thorac Oncol 2011, 6(4):813-817.
  • [47]Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 1955, 19:251-253.
  • [48]Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
  • [49]DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
  • [50]Cochran WG: The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
  • [51]Begg CB, Berlin JA, Begg CB, Berlin JA: Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989, 18(2):107-115. 81
  • [52]Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
  • [53]Kohno T, Sakiyama T, Kunitoh H, Goto K, Nishiwaki Y, et al.: Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Carcinogenesis 2006, 27:2448-2454.
  • [54]Weiss JM, Goode EL, Ladiges WC, Ulrich CM: Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005, 42:127-141.
  • [55]Hung RJ, Hall J, Brennan P, Boffetta P: Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 2005, 162(10):925-942.
  • [56]Li H, Hao X, Zhang W, Wei Q, Chen K: The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17(7):1739-1745.
  文献评价指标  
  下载次数:62次 浏览次数:24次